ginkgo bioworks hold

ginkgo bioworks hold

NYSE:DNA
Ginkgo Bioworks Holdings Inc.

Chart

Detailed Quote

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Featured Articles and Interviews
Press Releases

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

The Conversation (0)